BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE)
Clinical trials for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE) explained in plain language.
Never miss a new study
Get alerted when new BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE) trials appear
Sign up with your email to follow new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo offers hope for bladder cancer patients facing bladder removal
Disease control TerminatedThis study was testing a drug called NDV-01 (a combination of two chemotherapy medicines) for people with a type of bladder cancer that did not respond to the usual BCG treatment. The goal was to see if the drug could make the cancer disappear and help patients avoid having their…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE)
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Bladder cancer drug trial pulled before starting
Disease control TerminatedThis study was designed to test a new treatment called NDV-01 for people with a certain type of bladder cancer that hasn't spread into the muscle. The plan was to compare the drug against simply watching and waiting after surgery. However, the trial was withdrawn before any parti…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER SUPERFICIAL (NON-INVASIVE)
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC